ClinicalTrials.Veeva

Menu

Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Completed

Conditions

Preeclampsia

Study type

Observational

Funder types

Other

Identifiers

NCT01388283
INMARPE11

Details and patient eligibility

About

The purpose of this study is to assess the predictive role of serum inflammatory markers in pregnant women who subsequently develop preeclampsia.

Enrollment

129 patients

Sex

Female

Ages

20 to 43 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • caucasian,
  • nulliparous

Exclusion criteria

  • preexisting cardiovascular diseases,
  • diabetes,
  • hypertension,
  • inflammatory bowel diseases,
  • serious organ diseases, and
  • development of separate gestational diabetes and/or hypertension.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems